Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros












Base de datos
Idioma
Intervalo de año de publicación
1.
Vopr Virusol ; 40(5): 205-8, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-8659173

RESUMEN

Comparative analysis of the characteristics of tick-borne encephalitis (TBE) strain 205 used for the production of vaccine against TBE and of its variants obtained by passages in mouse brain showed the stability of such properties as infective activity, neurovirulence, sensitivity to physical (heating to 50 C) and chemical (sodium deoxycholate treatment) factors. At the same time increased neurovirulence of variants 205/M10 and 205/M20, which undergone through 10 and 20 passages in white mouse brain, for low-sensitive Syrian hamsters was revealed. Use of a panel of 5 monoclonal antibodies to protein E and of 4 monoclonal antibodies to protein E and of 4 monoclonal antibodies to protein NS3 helped differentiate between not only strains 205 and Sofyin, but between variants of strain 205 as well.


Asunto(s)
Virus de la Encefalitis Transmitidos por Garrapatas/inmunología , Animales , Encéfalo/virología , Cricetinae , Ácido Desoxicólico/farmacología , Virus de la Encefalitis Transmitidos por Garrapatas/efectos de los fármacos , Virus de la Encefalitis Transmitidos por Garrapatas/patogenicidad , Calor , Macaca mulatta , Mesocricetus , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Pase Seriado , Vacunas Virales , Virulencia
2.
Vopr Virusol ; 40(2): 82-5, 1995.
Artículo en Ruso | MEDLINE | ID: mdl-7539195

RESUMEN

Epitope specificity and protective activity of 5 types of monoclonal antibodies (MAB) to strain TM-14 of Venezuelan equine encephalomyelitis (VEE) virus were studied. The competing VEE A4 and VEE B5 MAB were shown to recognize the conformation-dependent epitope of glycoprotein E2 third site and to possess an extremely high protective activity. VEE C6 MAB were active in all the studied biological tests (hemagglutination inhibition, neutralization tests, passive defence) and were directed to glycoprotein E2 site six. Competitive radioimmunoassay demonstrated that VEE A5 MAB also interacted with E2-6 site and by the sum of characteristics detected a new epitope of this site. VEE G1 MAB specific to glycoprotein E1 were characterized by protective, but not neutralizing activity, and competed with MAB to sites E2-2 and E2-6. This means that VEE G1 MAB detect a heretofore not described epitope E1 overlapping with two E2 sites.


Asunto(s)
Anticuerpos Monoclonales/uso terapéutico , Encefalomielitis Equina Venezolana/prevención & control , Epítopos/inmunología , Animales , Anticuerpos Monoclonales/inmunología , Virus de la Encefalitis Equina Venezolana/inmunología , Pruebas de Hemaglutinación , Ratones , Pruebas de Neutralización , Radioinmunoensayo , Proteínas del Envoltorio Viral/inmunología
3.
Vopr Virusol ; 36(6): 495-8, 1991.
Artículo en Ruso | MEDLINE | ID: mdl-1723821

RESUMEN

Five strains of hybrid cells producing highly active monoclonal antibodies (MCA) to Venezuelan equine encephalomyelitis (VEE) virus were generated. VEEC6 MCA had high virus-neutralizing and hemagglutinating activities attesting to their direction to the "critical" site of E2 glycoprotein. MCA VEEA5 directed to the same glycoprotein did not overlap spatially with the previous one. MCA VEEB5 and VEEA4 interacted with conformational virus determinants taking part in hemagglutination.


Asunto(s)
Anticuerpos Monoclonales/inmunología , Virus de la Encefalitis Equina Venezolana/inmunología , Animales , Anticuerpos Monoclonales/análisis , Anticuerpos Monoclonales/aislamiento & purificación , Embrión de Pollo , Virus de la Encefalitis Equina Venezolana/aislamiento & purificación , Epítopos/inmunología , Inmunización , Inmunoquímica , Ratones , Ratones Endogámicos BALB C , Proteínas Virales de Fusión/inmunología , Cultivo de Virus
4.
Eksp Onkol ; 10(4): 59-62, 1988.
Artículo en Ruso | MEDLINE | ID: mdl-3181077

RESUMEN

The electrophoretic and spectral analyses have been used to show the possibility to form a complex consisting of doxorubicin and adriamycin with heparin, the molar ratio being 6:1 and pH 4.8-7.4. Doxorubicin and adriamycin had procoagulant properties but the doxorubicin-heparin complex showed an anticoagulant activity. In experiments on rats with the Pliss lymphosarcoma and sarcoma 45 the doxorubicin-heparin complex depressed more efficiently the tumour growth and metastasis spreading. The combination of doxorubicin and the doxorubicin heparin complex with the trypsin-heparin complex which imitate the hyperfunction of anticoagulative system markedly increased the antitumour effects.


Asunto(s)
Doxorrubicina/uso terapéutico , Hemostasis/efectos de los fármacos , Heparina/uso terapéutico , Neoplasias Experimentales/tratamiento farmacológico , Animales , Combinación de Medicamentos , Evaluación Preclínica de Medicamentos , Linfoma no Hodgkin/sangre , Linfoma no Hodgkin/tratamiento farmacológico , Linfoma no Hodgkin/secundario , Trasplante de Neoplasias , Neoplasias Experimentales/sangre , Neoplasias Experimentales/secundario , Ratas , Sarcoma Experimental/sangre , Sarcoma Experimental/tratamiento farmacológico , Sarcoma Experimental/secundario , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...